<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38695969</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Intervention modalities for brain fog caused by long-COVID: systematic review of the literature.</ArticleTitle><Pagination><StartPage>2951</StartPage><EndPage>2968</EndPage><MedlinePgn>2951-2968</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-024-07566-w</ELocationID><Abstract><AbstractText>Individuals suffering from long-COVID can present with "brain fog", which is characterized by a range of cognitive impairments, such as confusion, short-term memory loss, and difficulty concentrating. To date, several potential interventions for brain fog have been considered. Notably, no systematic review has comprehensively discussed the impact of each intervention type on brain fog symptoms. We included studies on adult (aged&#x2009;&gt;&#x2009;18&#xa0;years) individuals with proven long- COVID brain-fog symptoms from PubMed, MEDLINE, Central, Scopus, and Embase. A search limit was set for articles published between 01/2020 and 31/12/2023. We excluded studies lacking an objective assessment of brain fog symptoms and patients with preexisting neurological diseases that affected cognition before COVID-19 infection. This review provided relevant information from 17 studies. The rehabilitation studies utilized diverse approaches, leading to a range of outcomes in terms of the effectiveness of the interventions. Six studies described noninvasive brain stimulation, and all showed improvement in cognitive ability. Three studies described hyperbaric oxygen therapy, all of which showed improvements in cognitive assessment tests and brain perfusion. Two studies showed that the use of Palmitoylethanolamide and Luteolin (PEA-LUT) improved cognitive impairment. Noninvasive brain stimulation and hyperbaric oxygen therapy showed promising results in the treatment of brain fog symptoms caused by long-COVID, with improved perfusion and cortical excitability. Furthermore, both rehabilitation strategies and PEA-LUT administration have been associated with improvements in symptoms of brain fog. Future studies should explore combinations of interventions and include longer follow-up periods to assess the long-term effects of these treatments.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gorenshtein</LastName><ForeName>Alon</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-7542-8608</Identifier><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. alon323@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liba</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leibovitch</LastName><ForeName>Liron</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Shai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Yael</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Maccabi Healthcare Services, Tel Aviv-Yafo, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000711647">long COVID brain fog</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006931" MajorTopicYN="N">Hyperbaric Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065908" MajorTopicYN="N">Transcranial Direct Current Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050781" MajorTopicYN="N">Transcranial Magnetic Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="Y">Mental Fatigue</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">Intervention</Keyword><Keyword MajorTopicYN="N">Non-invasive brain stimulation</Keyword><Keyword MajorTopicYN="N">Oxygen therapy hyperbaric</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>13</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38695969</ArticleId><ArticleId IdType="pmc">PMC11176231</ArticleId><ArticleId IdType="doi">10.1007/s10072-024-07566-w</ArticleId><ArticleId IdType="pii">10.1007/s10072-024-07566-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parums DV. Editorial: A rapid global increase in COVID-19 is due to the emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2. Med Sci Monit. 2023;29:e942244. doi: 10.12659/MSM.942244.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.942244</ArticleId><ArticleId IdType="pmc">PMC10478578</ArticleId><ArticleId IdType="pubmed">37654205</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ. Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open. 2023;9:100033. doi: 10.1016/j.ajmo.2023.100033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajmo.2023.100033</ArticleId><ArticleId IdType="pmc">PMC9846887</ArticleId><ArticleId IdType="pubmed">36685609</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: One in three has neurological or psychiatric condition diagnosed after covid infection, study finds. BMJ. 2021;373:n908. doi: 10.1136/bmj.n908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n908</ArticleId><ArticleId IdType="pubmed">33827790</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghajani Mir M (2023) Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19. Mol Neurobiol. 10.1007/s12035-023-03715-y</Citation><ArticleIdList><ArticleId IdType="pubmed">37874482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam GY, Damant RW, Ferrara G, et al. Characterizing long-COVID brain fog: a retrospective cohort study. J Neurol. 2023;270(10):4640&#x2013;4646. doi: 10.1007/s00415-023-11913-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11913-w</ArticleId><ArticleId IdType="pubmed">37555926</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D, Liptakov&#xe1; E, Babi&#x10d;ov&#xe1; A, Batalik L, Ba&#x148;&#xe1;rov&#xe1; PS, Dobrodenkov&#xe1; S. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022;10:975992. doi: 10.3389/fpubh.2022.975992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordvig AS, Rajan M, Lau JD, et al. Brain fog in long COVID limits function and health status, independently of hospital severity and preexisting conditions. Front Neurol. 2023;14:1150096. doi: 10.3389/fneur.2023.1150096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1150096</ArticleId><ArticleId IdType="pmc">PMC10213727</ArticleId><ArticleId IdType="pubmed">37251229</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatys-Bogacka Z, Mazurkiewicz I, Slowik J, et al. Brain fog and quality of life at work in non-hospitalized patients after COVID-19. Int J Environ Res Public Health. 2022;19(19):12816. doi: 10.3390/ijerph191912816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912816</ArticleId><ArticleId IdType="pmc">PMC9564568</ArticleId><ArticleId IdType="pubmed">36232113</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolatt&#xfc;rk &#xd6;F, Soylu AC. Evaluation of cognitive, mental, and sleep patterns of post-acute COVID-19 patients and their correlation with thorax CT. Acta Neurol Belg. 2023;123(3):1089&#x2013;1093. doi: 10.1007/s13760-022-02001-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02001-3</ArticleId><ArticleId IdType="pmc">PMC9244055</ArticleId><ArticleId IdType="pubmed">35752747</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown LA, Ballentine E, Zhu Y, McGinley EL, Pezzin L, Abramoff B. The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection. Brain Behav Immun Health. 2022;22:100460. doi: 10.1016/j.bbih.2022.100460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100460</ArticleId><ArticleId IdType="pmc">PMC8983478</ArticleId><ArticleId IdType="pubmed">35403066</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Chen SJ, Chen YC, Tsai HC. A 30-year-old woman with an 8-week history of anxiety, depression, insomnia, and mild cognitive impairment following COVID-19 who responded to accelerated bilateral theta-burst transcranial magnetic stimulation over the prefrontal cortex. Am J Case Rep. 2023;24:e938732. doi: 10.12659/AJCR.938732.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.938732</ArticleId><ArticleId IdType="pmc">PMC10077184</ArticleId><ArticleId IdType="pubmed">37004143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferschmitt A, J&#xf6;bges M, Randerath J, Hinterberger T, Loew TH, K&#xf6;llner V. Attention deficits and depressive symptoms improve differentially after rehabilitation of post-COVID condition - A prospective cohort study. J Psychosom Res. 2023;175:111540. doi: 10.1016/j.jpsychores.2023.111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111540</ArticleId><ArticleId IdType="pubmed">37918327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki N, Yamatoku M, Tsuchida T, Sato H, Yamaguchi K. Effect of repetitive transcranial magnetic stimulation on long coronavirus disease 2019 with fatigue and cognitive dysfunction. Prog Rehabil Med. 2023;8:20230004. doi: 10.2490/prm.20230004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2490/prm.20230004</ArticleId><ArticleId IdType="pmc">PMC9968785</ArticleId><ArticleId IdType="pubmed">36861061</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca P, Camaioni A, Marra P, et al. Effect of ultra-micronized Palmitoylethanolamide and Luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. Cells. 2022;11(16):2552. doi: 10.3390/cells11162552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11162552</ArticleId><ArticleId IdType="pmc">PMC9406356</ArticleId><ArticleId IdType="pubmed">36010630</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Le&#xf3;n-Herrera S, Oliv&#xe1;n-Bl&#xe1;zquez B, M&#xe9;ndez-L&#xf3;pez F, Dom&#xed;nguez-Garc&#xed;a M, S&#xe1;nchez-Recio R. Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial. Sci Rep. 2023;13(1):7943. doi: 10.1038/s41598-023-35058-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35058-y</ArticleId><ArticleId IdType="pmc">PMC10187508</ArticleId><ArticleId IdType="pubmed">37193738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaiotti P, Cirac&#xec; C, Donelli D, et al. Effects of multidisciplinary rehabilitation enhanced with neuropsychological treatment on post-acute SARS-CoV-2 cognitive impairment (Brain Fog): An observational study. Brain Sci. 2023;13(5):791. doi: 10.3390/brainsci13050791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13050791</ArticleId><ArticleId IdType="pmc">PMC10216015</ArticleId><ArticleId IdType="pubmed">37239263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat AM, Sasson E, Wang Z, et al. Hyperbaric oxygen treatment for long coronavirus disease-19: a case report. J Med Case Rep. 2022;16(1):80. doi: 10.1186/s13256-022-03287-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysoki&#x144;ski A, Szczepocka E, Szczakowska A. Improved cognitive performance, increased theta, alpha, beta and decreased delta powers after cognitive rehabilitation augmented with tDCS in a patient with post-COVID-19 cognitive impairment (brain-fog) Psychiatry Res Case Rep. 2023;2(2):100164. doi: 10.1016/j.psycr.2023.100164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psycr.2023.100164</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga LW, Oliveira SB, Moreira AS, et al. Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant? NeuroRehabilitation. 2023;53(4):517&#x2013;534. doi: 10.3233/NRE-230212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-230212</ArticleId><ArticleId IdType="pubmed">38143394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel BA, Zhou W, Huber F, et al. Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment. Restor Neurol Neurosci. 2021;39(6):393&#x2013;408. doi: 10.3233/RNN-211249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-211249</ArticleId><ArticleId IdType="pmc">PMC8764598</ArticleId><ArticleId IdType="pubmed">34924406</ArticleId></ArticleIdList></Reference><Reference><Citation>Du&#xf1;abeitia JA, Mera F, Baro &#xd3;, Jadad-Garcia T, Jadad AR. Personalized computerized training for cognitive dysfunction after COVID-19: A before-and-after feasibility pilot study. Int J Environ Res Public Health. 2023;20(4):3100. doi: 10.3390/ijerph20043100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043100</ArticleId><ArticleId IdType="pmc">PMC9966004</ArticleId><ArticleId IdType="pubmed">36833793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausswirth C, Schmit C, Rougier Y, Coste A. Positive Impacts of a four-week neuro-meditation program on cognitive function in post-acute sequelae of COVID-19 patients: A randomized controlled trial. Int J Environ Res Public Health. 2023;20(2):1361. doi: 10.3390/ijerph20021361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021361</ArticleId><ArticleId IdType="pmc">PMC9858974</ArticleId><ArticleId IdType="pubmed">36674117</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y, Sato A, Shichi M, et al. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J Psychiatr. 2023;81:103438. doi: 10.1016/j.ajp.2022.103438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103438</ArticleId><ArticleId IdType="pmc">PMC9795803</ArticleId><ArticleId IdType="pubmed">36610206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12:11252. doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen R, Arany PR. Use of either transcranial or whole-body photobiomodulation treatments improves COVID-19 brain fog. J Biophotonics. 2023;16(8):e202200391. doi: 10.1002/jbio.202200391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202200391</ArticleId><ArticleId IdType="pubmed">37018063</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T, Gonevski M, Clark C, et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond) 2021;21(6):e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenacchi V, Furlanis G, Menichelli A, Lunardelli A, Pesavento V, Manganotti P. Co-ultraPEALut in subjective cognitive impairment following SARS-CoV-2 infection: An exploratory retrospective study. Brain Sci. 2024;14(3):293. doi: 10.3390/brainsci14030293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci14030293</ArticleId><ArticleId IdType="pmc">PMC10968982</ArticleId><ArticleId IdType="pubmed">38539680</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L, Kudlicka A, Oyebode JR, et al. Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: A multicentre randomised controlled trial (the GREAT trial) Int J Geriatr Psychiatry. 2019;34(5):709&#x2013;721. doi: 10.1002/gps.5076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5076</ArticleId><ArticleId IdType="pmc">PMC6593854</ArticleId><ArticleId IdType="pubmed">30724405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlicka A, Martyr A, Bahar-Fuchs A, Sabates J, Woods B, Clare L. Cognitive rehabilitation for people with mild to moderate dementia. Cochrane Database Syst Rev. 2023;6(6):CD013388. doi: 10.1002/14651858.CD013388.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013388.pub2</ArticleId><ArticleId IdType="pmc">PMC10310315</ArticleId><ArticleId IdType="pubmed">37389428</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger KC, Martinez AP, Hyland MH. The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot study. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211040239. doi: 10.1177/20552173211040239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20552173211040239</ArticleId><ArticleId IdType="pmc">PMC8404656</ArticleId><ArticleId IdType="pubmed">34471544</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrachi Y, Shahrabani S, Nachmani M, Hornik A. Obstacles to using online health services among adults age 50 and up and the role of family support in overcoming them. Isr J Health Policy Res. 2020;9(1):42. doi: 10.1186/s13584-020-00398-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-020-00398-x</ArticleId><ArticleId IdType="pmc">PMC7441221</ArticleId><ArticleId IdType="pubmed">32825840</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauta IM, Bertens D, Fasotti L, et al. Cognitive rehabilitation and mindfulness reduce cognitive complaints in multiple sclerosis (REMIND-MS): A randomized controlled trial. Mult Scler Relat Disord. 2023;71:104529. doi: 10.1016/j.msard.2023.104529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2023.104529</ArticleId><ArticleId IdType="pubmed">36736039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill NT, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A. Computerized Cognitive training in older adults with mild cognitive impairment or dementia: A systematic review and meta-analysis. Am J Psychiatry. 2017;174(4):329&#x2013;340. doi: 10.1176/appi.ajp.2016.16030360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2016.16030360</ArticleId><ArticleId IdType="pubmed">27838936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesikburun S. Non-invasive brain stimulation in rehabilitation. Turk J Phys Med Rehabil. 2022;68(1):1&#x2013;8. doi: 10.5606/tftrd.2022.10608.</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/tftrd.2022.10608</ArticleId><ArticleId IdType="pmc">PMC9305642</ArticleId><ArticleId IdType="pubmed">35949977</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscutti A, De Figueiredo JM, Razouq D, Murphy N, Cho R, Selvaraj S. Noninvasive brain stimulation techniques for treatment-resistant depression: Transcranial Magnetic stimulation and transcranial direct current stimulation. Psychiatr Clin North Am. 2023;46(2):307&#x2013;329. doi: 10.1016/j.psc.2023.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2023.02.005</ArticleId><ArticleId IdType="pubmed">37149347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Guo Z, Du Y, et al. Effects of noninvasive brain stimulation (NIBS) on cognitive impairment in mild cognitive impairment and alzheimer disease: A meta-analysis. Alzheimer Dis Assoc Disord. 2021;35(3):278&#x2013;288. doi: 10.1097/WAD.0000000000000464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000464</ArticleId><ArticleId IdType="pubmed">34432674</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse A, Kritzer MD, Eryilmaz H, et al. Neurocircuitry hypothesis and clinical experience in treating neuropsychiatric symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2. J Acad Consult Liaison Psychiatry. 2022;63(6):619&#x2013;627. doi: 10.1016/j.jaclp.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9404079</ArticleId><ArticleId IdType="pubmed">36030055</ArticleId></ArticleIdList></Reference><Reference><Citation>Jannati A, Oberman LM, Rotenberg A, Pascual-Leone A. Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. Neuropsychopharmacology. 2023;48(1):191&#x2013;208. doi: 10.1038/s41386-022-01453-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-022-01453-8</ArticleId><ArticleId IdType="pmc">PMC9700722</ArticleId><ArticleId IdType="pubmed">36198876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of low-level laser therapy in neurorehabilitation. PM R. 2010;2(12 Suppl 2):S292&#x2013;S305. doi: 10.1016/j.pmrj.2010.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmrj.2010.10.013</ArticleId><ArticleId IdType="pmc">PMC3065857</ArticleId><ArticleId IdType="pubmed">21172691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000;527(Pt 3(Pt 3)):633&#x2013;639. doi: 10.1111/j.1469-7793.2000.t01-1-00633.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.2000.t01-1-00633.x</ArticleId><ArticleId IdType="pmc">PMC2270099</ArticleId><ArticleId IdType="pubmed">10990547</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayan E, Cohen LG. Neuroplasticity subserving motor skill learning. Neuron. 2011;72(3):443&#x2013;454. doi: 10.1016/j.neuron.2011.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.10.008</ArticleId><ArticleId IdType="pmc">PMC3217208</ArticleId><ArticleId IdType="pubmed">22078504</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvert JW, Cahill J, Zhang JH. Hyperbaric oxygen and cerebral physiology. Neurol Res. 2007;29(2):132&#x2013;141. doi: 10.1179/016164107X174156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164107X174156</ArticleId><ArticleId IdType="pubmed">17439697</ArticleId></ArticleIdList></Reference><Reference><Citation>Alashram AR, Padua E, Romagnoli C, Annino G. Hyperbaric oxygen therapy for cognitive impairments in patients with traumatic brain injury: A systematic review. Appl Neuropsychol Adult. 2023;30(5):602&#x2013;613. doi: 10.1080/23279095.2022.2041418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2022.2041418</ArticleId><ArticleId IdType="pubmed">35213282</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinkowska AB, Mankowska ND, Kot J, Winklewski PJ. Impact of hyperbaric oxygen therapy on cognitive functions: A systematic review. Neuropsychol Rev. 2022;32(1):99&#x2013;126. doi: 10.1007/s11065-021-09500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-021-09500-9</ArticleId><ArticleId IdType="pmc">PMC8888529</ArticleId><ArticleId IdType="pubmed">33847854</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Zhang F, Zhao L, et al. Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment. Alzheimers Dement (N Y) 2020;6(1):e12030. doi: 10.1002/trc2.12030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12030</ArticleId><ArticleId IdType="pmc">PMC7293997</ArticleId><ArticleId IdType="pubmed">32548235</ArticleId></ArticleIdList></Reference><Reference><Citation>Senniappan K, Jeyabalan S, Rangappa P, Kanchi M. Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19? Indian J Anaesth. 2020;64(10):835&#x2013;841. doi: 10.4103/ija.IJA_613_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_613_20</ArticleId><ArticleId IdType="pmc">PMC7791429</ArticleId><ArticleId IdType="pubmed">33437070</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Villalobos I, Casanova-Maldonado I, Lois P, et al. Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCs in diabetic mice. Front Physiol. 2018;9:995. doi: 10.3389/fphys.2018.00995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00995</ArticleId><ArticleId IdType="pmc">PMC6078002</ArticleId><ArticleId IdType="pubmed">30104981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Daugherty WP, Sun D, et al. Protection of mitochondrial function and improvement in cognitive recovery in rats treated with hyperbaric oxygen following lateral fluid-percussion injury. J Neurosurg. 2007;106(4):687&#x2013;694. doi: 10.3171/jns.2007.106.4.687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.2007.106.4.687</ArticleId><ArticleId IdType="pubmed">17432723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadanny A, Bechor Y, Catalogna M, et al. Hyperbaric oxygen therapy can induce neuroplasticity and significant clinical improvement in patients suffering from fibromyalgia with a history of childhood sexual abuse-randomized controlled trial. Front Psychol. 2018;9:2495. doi: 10.3389/fpsyg.2018.02495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.02495</ArticleId><ArticleId IdType="pmc">PMC6304433</ArticleId><ArticleId IdType="pubmed">30618929</ArticleId></ArticleIdList></Reference><Reference><Citation>Efrati S, Ben-Jacob E. Reflections on the neurotherapeutic effects of hyperbaric oxygen. Expert Rev Neurother. 2014;14(3):233&#x2013;236. doi: 10.1586/14737175.2014.884928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2014.884928</ArticleId><ArticleId IdType="pubmed">24471697</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive improvement. Biomolecules. 2021;11(10):1520. doi: 10.3390/biom11101520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11101520</ArticleId><ArticleId IdType="pmc">PMC8533945</ArticleId><ArticleId IdType="pubmed">34680155</ArticleId></ArticleIdList></Reference><Reference><Citation>Raciti L, Arcadi FA, Calabr&#xf2; RS. Could palmitoylethanolamide be an effective treatment for long-COVID-19? hypothesis and insights in potential mechanisms of action and clinical applications. Innov Clin Neurosci. 2022;19(1&#x2013;3):19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970234</ArticleId><ArticleId IdType="pubmed">35382075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnelli G, Gigli S, Capoccia E, et al. Palmitoylethanolamide exerts antiproliferative effect and downregulates VEGF signaling in Caco-2 human colon carcinoma cell line through a selective PPAR-&#x3b1;-dependent inhibition of Akt/mTOR pathway. Phytother Res. 2016;30(6):963&#x2013;970. doi: 10.1002/ptr.5601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.5601</ArticleId><ArticleId IdType="pubmed">26929026</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agostino G, Russo R, Avagliano C, Cristiano C, Meli R, Calignano A. Palmitoylethanolamide protects against the amyloid-&#x3b2;25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease. Neuropsychopharmacology. 2012;37(7):1784&#x2013;1792. doi: 10.1038/npp.2012.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.25</ArticleId><ArticleId IdType="pmc">PMC3358748</ArticleId><ArticleId IdType="pubmed">22414817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WS, Barrett DA, Randall MD. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol. 2008;155(6):837&#x2013;846. doi: 10.1038/bjp.2008.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjp.2008.324</ArticleId><ArticleId IdType="pmc">PMC2597234</ArticleId><ArticleId IdType="pubmed">18695637</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriano M, Esposito G, Negro L, et al. Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of &#x3b2; amyloid-induced astrogliosis in vitro. CNS Neurol Disord Drug Targets. 2015;14(7):828&#x2013;837. doi: 10.2174/1871527314666150317224155.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527314666150317224155</ArticleId><ArticleId IdType="pubmed">25801844</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A. 2022;119(35):e2200960119. doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. BioFactors. 2021;47(2):232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E, Inigo J, Chandra D, et al. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID [published correction appears in J Neuroimmune Pharmacol. 2021 Dec 11;:] J Neuroimmune Pharmacol. 2021;16(4):770&#x2013;784. doi: 10.1007/s11481-021-10015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10015-6</ArticleId><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercegovac M, Asanin M, Savic-Radojevic A, et al. Antioxidant genetic profile modifies probability of developing neurological sequelae in long-COVID. Antioxidants (Basel) 2022;11(5):954. doi: 10.3390/antiox11050954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11050954</ArticleId><ArticleId IdType="pmc">PMC9138155</ArticleId><ArticleId IdType="pubmed">35624818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Lindmark K, Fors Connolly AM. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599&#x2013;607. doi: 10.1016/S0140-6736(21)00896-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodella C, Bernini S, Panzarasa S, et al. A double-blind randomized controlled trial combining cognitive training (CoRe) and neurostimulation (tDCS) in the early stages of cognitive impairment. Aging Clin Exp Res. 2022;34(1):73&#x2013;83. doi: 10.1007/s40520-021-01912-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01912-0</ArticleId><ArticleId IdType="pubmed">34156651</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>